Ordinance
on Clinical Trials
with the exception of
Clinical Trials of Medical Devices1
(Clinical Trials Ordinance, ClinO)

1 Amended by Annex 2 No 2 of the O of 1 July 2020 on Clinical Trials of Medical Devices, in force since 26 May 2021 (AS 2020 3033).


Open article in different language:  DE  |  FR  |  IT
Art. 36 Clinical trials of medicinal products capable of emitting ionising radiation 77

1 For Cat­egory B and C clin­ic­al tri­als of medi­cin­al products cap­able of emit­ting ion­ising ra­di­ation, the doc­u­ments spe­cified in An­nex 4 num­ber 5 must ad­di­tion­ally be sub­mit­ted to Swiss­med­ic.78

2 In the case of Cat­egory C clin­ic­al tri­als, Swiss­med­ic shall seek an opin­ion from the FOPH be­fore grant­ing ap­prov­al. The FOPH shall re­view com­pli­ance with ra­di­olo­gic­al pro­tec­tion le­gis­la­tion and the dose es­tim­a­tion.79

3 Swiss­med­ic shall grant ap­prov­al if:

a.
the re­quire­ments covered by Art­icle 32 are met; and
b.
the FOPH has raised no ob­jec­tions to the clin­ic­al tri­al.

4 Swiss­med­ic shall reach a de­cision on Cat­egory C clin­ic­al tri­als with­in 60 days of ac­know­ledge­ment of re­ceipt of the form­ally cor­rect ap­plic­a­tion doc­u­ments. Swiss­med­ic shall in­form the FOPH of its de­cision.

580

77 Amended by No I of the O of 7 June 2024, in force since 1 Nov. 2024 (AS 2024 322).

78 Amended by No I of the O of 7 June 2024, in force since 1 Nov. 2024 (AS 2024 322).

79 Amended by No I of the O of 7 June 2024, in force since 1 Nov. 2024 (AS 2024 322).

80 Re­pealed by No I of the O of 7 June 2024, with ef­fect from 1 Nov. 2024 (AS 2024 322).

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden